Advanced Search

Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 1998 March;40(1) > Panminerva Medica 1998 March;40(1):66-8



A Journal on Internal Medicine

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Frequency: Quarterly

ISSN 0031-0808

Online ISSN 1827-1898


Panminerva Medica 1998 March;40(1):66-8


Acute myositis following autologus bone marrow transplantation (BMT)

Miniero R., Soldano S., Vassallo E., Busca A., Gruppi E., Colombini A.*, Barzaghi A.*, Uderzo C.*

From the Department of Pediatrics, University of Turin, Italy
* Department of Pediatrics, University of Milan, Italy

A 4-year-old boy with acute myeloid leukemia developed acute myositis associated with refractory thrombocytopenia one month after autologous bone marrow transplantation (BMT). Clinical, electromyographic and biohumoral features were consistent with the diagnosis of myositis. The patient responded to corticosteroids, and 39 months after BMT he is in complete remission and has regained good muscle function. Although we could not determine with certainty the specific pathophysiologic mechanism of this complication, it should be pointed out that acute myositis can occur in the early post-BMT period.

language: English


top of page